Rapid determination of serum amyloid A using an upconversion luminescent lateral flow immunochromatographic strip.
Xinwen SunXiaoru DaiShisheng LingWenkun DongDong ChenMengting LiXvsheng QiaoZhiyu WangXianping FanGuodong QianPublished in: The Analyst (2023)
The early diagnosis and real-time prognosis of cardiovascular diseases (CVDs) at the bedside are important. However, real-time detection of myocardial infarction involves the use of large-scale instrumentation and long test times. Herein, a simple, rapid and sensitive lateral flow immunochromatographic strip (LFIS) based on Yb/Er co-doped NaYF 4 upconversion nanoparticles (UCNPs) was demonstrated for use in the detection of myocardial infarction. First, through heavy Yb/Er doping and an inert NaYF 4 shell coating on the nanoparticles, the surface-related luminescence quenching effect of UCNPs was eliminated to enhance the upconversion luminescence. Second, through uniform coating of a SiO 2 layer on the UCNPs, the biological affinity was improved to couple UCNPs and antibody proteins. Finally, through modification and activation with a specific antibody protein (serum amyloid A (SAA)), the UCNPs exhibited intense upconversion luminescence and high specificity when applied as a lateral flow immunochromatographic strip (LFIS). The developed UC-LFIS was highly sensitive (0.1 μg mL -1 ) and specific for detecting SAA in only 10 μL of serum. The UC-LFIS holds great potential for the early diagnosis and prognosis of CVDs.
Keyphrases
- energy transfer
- quantum dots
- loop mediated isothermal amplification
- sensitive detection
- heart failure
- cardiovascular disease
- left ventricular
- estrogen receptor
- label free
- molecularly imprinted
- real time pcr
- endoplasmic reticulum
- type diabetes
- photodynamic therapy
- coronary artery disease
- human health
- risk assessment
- climate change
- high resolution
- single molecule
- light emitting
- metal organic framework